Table 1.

Baseline demographics and clinical characteristics (ITT Population)

Ferumoxytol 2 × 510 mg n = 114Oral Iron 200 mg/d n = 116
Age, mean ± SD (yr)59.5 ± 14.360.8 ± 13.0
Gender, n (%) male57 (50.0)73 (62.9)
Race, n (%)
    African American69 (60.5)67 (57.8)
    Caucasian37 (32.5)40 (34.5)
    Asian6 (5.3)2 (1.7)
    other/missing2 (1.8)7 (6.0)
Cause of kidney disease, n (%)
    diabetes49 (42.9)49 (42.2)
    hypertension39 (34.2)40 (34.5)
    glomerular disease11 (9.6)7 (6.0)
    other/missing15 (13.2)20 (17.2)
Laboratory values, mean ± SD
    hemoglobin (g/dl)10.59 ± 0.6710.69 ± 0.57
    TSAT (%)15.71 ± 7.2115.91 ± 6.29
    ferritin (ng/ml)341 ± 159358 ± 172
  • TSAT, transferrin saturation.